New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
10:12 EDTMDCO, BMYThe Medicines Co. and Bristol-Myers' Recothrom collaboration becomes effective
The Medicines Company (MDCO) announced that the global license and two-year collaboration for Recothrom, a recombinant thrombin approved by the FDA for use as a topical hemostat to control non-arterial bleeding during surgical procedures, established with Bristol-Myers Squibb Company (BMY), has become effective. The agreement was first announced in December 2012. The companies have satisfied all required regulatory and closing conditions.
News For MDCO;BMY From The Last 14 Days
Check below for free stories on MDCO;BMY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 22, 2014
07:21 EDTBMYEBD Group to hold a conference
Subscribe for More Information
September 17, 2014
07:43 EDTBMYBofA/Merrill to hold a conference
Subscribe for More Information
September 16, 2014
06:00 EDTBMYBristol-Myers announces Health Canada approval of Yervoy
Subscribe for More Information
September 12, 2014
12:12 EDTMDCOThe Medicines Co. to host conference call
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use